Financials
Value Q1, 25Q2, 25 TTM Selling/general/admin expenses 235.15 M234.99 M — Research & development —— — Operating income 17.29 M78.49 M — Non-Operating Income, Total -15.11 M1.06 M — Interest expense, net of interest capitalized 15.3 M1.89 M — Non-Operating Income, excl. Interest Expenses -30.41 M-2.16 M — Unusual income/expense 01.33 M — Pretax income 2.18 M79.55 M — Equity in earnings —— — Taxes -334 K21.75 M — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 2.52 M57.8 M — Discontinued operations —— — Net income 2.52 M57.8 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 2.52 M57.8 M — Basic earnings per share (Basic EPS) 0.020.44 — Diluted earnings per share (Diluted EPS) 0.020.43 — Average basic shares outstanding 122.23 M130.63 M — Diluted shares outstanding 128.11 M135.64 M — EBITDA 35.91 M98.17 M — EBIT 17.29 M78.49 M — Cost of revenue 321.59 M300.51 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 18.61 M19.68 M —